Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03539198
What this trial is testing

Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Mayo Clinic 19
Not applicableActive Not RecruitingNCT05914506
What this trial is testing

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease

Who this might be right for
Progressive Fibrosing Interstitial Lung Disease
University of Aarhus 30
Not applicableStudy completedNCT05312749
What this trial is testing

The Effect of Web Based Progressive Muscle Relaxation Exercise on Clinical Stress and Anxiety of Nursing Students

Who this might be right for
AnxietyStressNursing Students+1 more
Ataturk University 66
Not applicableLooking for participantsNCT07723872
What this trial is testing

Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease (ILD)Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis+2 more
Hospital de Granollers 100
Not applicableLooking for participantsNCT02740634
What this trial is testing

Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study

Who this might be right for
Atypical Alzheimer's DiseaseLogopenic Progressive Aphasia (LPA)Posterior Cortical Atrophy (PCA)+5 more
Mayo Clinic 60
Not applicableStudy completedNCT04806763
What this trial is testing

Myopia Control With Orthokeratology Contact Lenses in Spain

Who this might be right for
Myopia, ProgressiveChildren, OnlyContact Lens Complication+2 more
Menicon Co., Ltd. 69
Not applicableStudy completedNCT07571967
What this trial is testing

AI-Assisted Camera-Based Progressive Muscle Relaxation for Office Workers

Who this might be right for
Musculoskeletal PainNeck PainStress, Physiological+1 more
Istanbul Medipol University Hospital 60
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Early research (Phase 1)WithdrawnNCT05029609
What this trial is testing

Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple SclerosisMultiple Sclerosis
Tiziana Life Sciences LTD
Large-scale testing (Phase 3)Active Not RecruitingNCT04689828
What this trial is testing

177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Novartis Pharmaceuticals 469
Not applicableStudy completedNCT07589816
What this trial is testing

Neuro-Athletic Training on Goalkeeper Performance

Who this might be right for
Athletic PerformanceAthletic Performance EnhancementNeuromuscular Adaptations
Coşkun YILMAZ 16
Testing effectiveness (Phase 2)Ended earlyNCT04088500
What this trial is testing

Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 5
Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Not applicableUnknownNCT03552211
What this trial is testing

Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
University Hospital, Clermont-Ferrand 3,000
Large-scale testing (Phase 3)Ended earlyNCT02144012
What this trial is testing

Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Hoffmann-La Roche 49
Testing effectiveness (Phase 2)Study completedNCT00923299
What this trial is testing

Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine

Who this might be right for
Pancreatic Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 33
Not applicableUnknownNCT00306657
What this trial is testing

Normal Tension and Chronic Open Angle Glaucoma and Cerebrospinal Fluid Composition

Who this might be right for
Glaucoma Open-Angle
Kantonsspital Aarau 30
Testing effectiveness (Phase 2)WithdrawnNCT05222165
What this trial is testing

Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations

Who this might be right for
Advanced Solid TumorCNS TumorRecurrent WHO Grade II Glioma
Helsinn Healthcare SA
Not applicableUnknownNCT05433792
What this trial is testing

To Evaluate the Effectiveness of New Specially Designed Fitlens Soft Lens.

Who this might be right for
Myopia
Fitlens Ltd. 66
Testing effectiveness (Phase 2)Study completedNCT00131911
What this trial is testing

Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+7 more
National Cancer Institute (NCI) 93
Next Page